CytoSorbents Announces $6.25 Mln Stock Financing; Agrees With Avenue Capital On A Debt Amendment
(RTTNews) - CytoSorbents Corp. (CTSO), a medical device company specializing in blood purification technologies, Friday announced a $6.25 million stock financing and an agreement with Avenue Capital Group to reduce debt and extend its loan maturity.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.